Gå direkt till huvudinnehållet

Antikoagulationsbehandling – warfarin, heparin, LMH

Senast uppdaterad: Publicerad:


  1. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 suppl): 204-33.
  2. Du Breuil AL, Umland EM. Outpatient management of anticoagulation therapy. Am Fam Physician 2007; 75: 1031-42. PubMed  
  3. Warfarin food interactions. Pharmacist's Letter/Prescriber's Letter 2005; 21: 210507.
  4. Antikoagulantiabehandling vid förmaksflimmer - behandlingsrekommendation: Information från Läkemedelsverket 2017;28(1):12–31. lakemedelsverket.se  
  5. Mannheimer B, Lindh J. Ökad risk för tromboembolism vid warfarin och flukloxacillin. Läkartidningen 2019; 116: FTLH. www.lakartidningen.se  
  6. Crowther MA, Ginsberg JB, Kearon C, Harrison L, Johnson J, Massicotte MP, et al. A randomized trial comparing 5-mg and 10-mg warfarin loading doses. Arch Intern Med 1999; 159: 46-8. PubMed  
  7. Kovacs MJ, Rodger M, Anderson DR, Morrow B, Kells G, Kovacs J, et al. Comparison of 10-mg and 5-mg warfarin initiation nomograms together with low-molecular-weight heparin for outpatient treatment of acute venous thromboembolism: a randomized, double-blind, controlled trial. Ann Intern Med 2003; 138: 714-9. Annals of Internal Medicine  
  8. Självtestning och egenvård vid användning av blodproppsförebyggande läkemedel. SBU:s Upplysningstjänst. 2014-10-08. www.sbu.se  
  9. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 suppl): 188-203.
  10. Magnusson P, Matsson G. Faktor Xa-hämmare likvärdiga med lågmolekylärt heparin. Läkartidningen. 2021;118:20224. lakartidningen.se  
  11. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med 2000; 160: 181-8. PubMed  
  12. Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl): 401-28.
  13. Trujillo-Santos J, Perea-Milla E, Jimenez-Puente A, Sanchez-Cantalejo E, del Toro J, Grau E, et al., for the RIETE Investigators. Bed rest or ambulation in the initial treatment of patients with acute deep vein thrombosis or pulmonary embolism: findings from the RIETE registry. Chest 2005; 127: 1631-6. PubMed  
  14. Kolbach DN, Sandbrink MW, Hamulyak K, Neumann HA, Prins MH. Non-pharmaceutical measures for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev, issue 1, 2004. The Cochrane Library  
  15. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl): 338-400.
  16. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126 (3 suppl): 429-56.
  17. Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, et al. Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126(3 suppl): 457-82.
  18. Jafri SM. Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. Am Heart J 2004; 147: 3-15. PubMed  
  19. Spyropoulos AC, Frost FJ, Hurley JS, Roberts M. Costs and clinical outcomes associated with low-molecular-weight heparin vs unfractionated heparin for perioperative bridging in patients receiving long-term oral anticoagulant therapy. Chest 2004; 125: 1642-50. PubMed  
  20. Spandorfer J. The management of anticoagulation before and after procedures. Med Clin North Am 2001; 85: 1109-16. PubMed  
  21. Dunn AS, Turpie AG. Perioperative management of patients receiving oral anticoagulants: a systematic review. Arch Intern Med 2003; 163: 901-8. PubMed  
  22. Dunn A. Perioperative management of oral anticoagulation: when and how to bridge. J Thromb Thrombolysis 2006; 21: 85-9. PubMed  
  • Peter J Svensson, professor och överläkare, Koagulationscentrum, Skånes universitetssjukhus

Tidigare sakkunniga

  • Terje Johannessen, professor i allmänmedicin, Institutt for samfunnsmedisinske fag, Norges teknisk-naturvitenskapelige universitet, Trondheim